# Michael Andersson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-andersson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,197 |
| Field | Breast Cancer Treatment Studies |
| h-index | 46 |
| i10-index | 102 |
| Last Known Institution | University of Copenhagen |
| OpenAlex ID | https://openalex.org/A5101542399 |
| ORCID iD | https://orcid.org/0000-0003-4440-4800 |
| Works | 175 |

## Researcher papers

- [Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer](https://scholariq.org/papers/trastuzumab-after-adjuvant-chemotherapy-in-her2-positive-breast-cancer/)
- [Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study](https://scholariq.org/papers/phase-iii-randomized-study-comparing-docetaxel-plus-trastuzumab-with-vinorelbine/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Risks and Factors](https://scholariq.org/topics/cancer-risks-and-factors/)

## Researcher university

- [University of Copenhagen](https://scholariq.org/institutions/university-of-copenhagen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.